Prevalence and outcomes of non‐alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States
Pegah Golabi(Inova Health System), Zobair M. Younossi(Georgetown University), James M. Paik(Inova Health System), Jessica Hwang(The University of Texas MD Anderson Cancer Center), Hannah M. Lee(Hunter Holmes McGuire VA Medical Center), Su Wang(Rutgers, The State University of New Jersey)
Cited by 60
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789